Search
for
Sort by
Research 901–930 of 1000+
- Acute Alopecia Associated With Albendazole Toxicosis
- Subject Index
- Sulfasalazine for alopecia areata
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- A New Application in Dermatological Ultrasound
- Deficient and/or insufficient serum 25 hydroxy vitamin D in patients with alopecia areata: is it a fact or a fiction?
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Weight Gain and Hair Loss during Anti-TNF Therapy
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- S100 signaling in hair follicle biology: emerging mechanistic insights and therapeutic opportunities
- Evaluation of vitamin D in pediatric alopecia areata: A case–control study of thirty patients in a tertiary care hospital
- Comorbidities in patients with alopecia areata
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- SIRT1 downregulation provokes immune-inflammatory responses in hair follicle outer root sheath cells and may contribute to development of alopecia areata
- The gut microbiome and Alopecia areata: Implications for early diagnostic biomarkers and novel therapies
- Systemic Lupus Erythematosus Presenting as Alopecia Areata
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Comparison of Platelet-Rich Plasma Therapy Versus Intralesional Triamcinolone Acetonide in the Treatment of Alopecia Areata: A Single-Blinded, Randomised Controlled Trial
- 0282 Effect of systemic immunomodulators on incidence of alopecia areata: A retrospective cohort study
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- New insights into the phenomenon of remissions and relapses in autoimmune diseases and the puzzle of benign autoantibodies in healthy individuals
- Serum Vitamin D Level in Pediatric Alopecia Areata
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- Effects of age and sex on the comorbidities of alopecia areata: A cross‐sectional hospital‐based study
- 148 Decreased IL-10 producing regulatory B cells in patients with alopecia areata
- Trends in the presence or absence of transaminitis and/or leukopenia in pediatric patients treated with methotrexate for inflammatory skin disease